信隆健康(002105) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 reached ¥585,539,472.88, representing a 149.42% increase compared to ¥234,761,032.32 in the same period last year[8] - Net profit attributable to shareholders was ¥59,397,700.22, a significant turnaround from a loss of ¥6,497,831.29, marking an increase of 1,014.12%[8] - The net profit after deducting non-recurring gains and losses was ¥55,160,678.45, compared to a loss of ¥10,135,373.88, reflecting a 644.24% improvement[8] - Basic earnings per share rose to ¥0.163 from a loss of ¥0.018, an increase of 1,005.56%[8] - The weighted average return on equity improved to 8.69%, up 9.88 percentage points from -1.19%[8] - Net profit for Q1 2021 was ¥65.25 million, representing a remarkable increase of 730.43% from a net loss of ¥10.35 million in Q1 2020[16] - Operating profit for Q1 2021 reached CNY 70,429,974.32, a significant increase from a loss of CNY 13,844,985.29 in the same period last year[41] - The total comprehensive income for Q1 2021 was CNY 65,337,683.13, compared to a loss of CNY 10,075,610.10 in the previous year[42] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,903,756,096.17, a 3.75% increase from ¥1,834,878,332.28 at the end of the previous year[8] - The total liabilities rose slightly to CNY 1,127,060,577.77 from CNY 1,123,520,497.01, showing a marginal increase of about 0.2%[33] - The owner's equity increased to CNY 776,695,518.40 from CNY 711,357,835.27, representing an increase of approximately 9.2%[34] - The total current liabilities amounted to CNY 990,619,766.70, compared to CNY 981,497,937.57 in the previous period, indicating an increase of approximately 0.1%[33] Cash Flow - The net cash flow from operating activities was negative at -¥15,971,124.05, a decline of 125.30% compared to ¥63,131,847.87 in the same period last year[8] - Operating cash inflow for the current period was CNY 592,070,605.19, an increase from CNY 475,061,088.23 in the previous period, representing a growth of approximately 24.7%[49] - Cash outflow from operating activities totaled CNY 608,041,729.24, compared to CNY 411,929,240.36 in the prior period, indicating an increase of about 47.5%[49] - Cash inflow from investment activities was CNY 1,027,342.94, up from CNY 553,253.37, marking an increase of approximately 85.8%[49] - Cash outflow from investment activities rose to CNY 17,644,469.06 from CNY 6,070,712.95, reflecting an increase of about 190.5%[49] - Cash inflow from financing activities was CNY 132,117,249.51, down from CNY 240,874,241.97, a decrease of approximately 45.0%[50] - The net cash flow from financing activities was negative CNY 18,861,792.14, a decline from a positive CNY 7,610,421.50 in the previous period[50] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,628[11] - Net assets attributable to shareholders increased by 9.09% to ¥713,532,470.06 from ¥654,098,080.95[8] Research and Development - Research and development expenses surged by 218.98% to ¥13.64 million, up from ¥4.28 million in the same period last year, indicating increased investment in innovation[15] - Research and development expenses increased to CNY 13,639,220.44 in Q1 2021, up from CNY 4,275,879.16 in the same period last year, reflecting a focus on innovation[41] Inventory and Receivables - Accounts receivable rose by 20.86% to ¥568.52 million, reflecting a substantial increase in revenue and corresponding receivables[15] - The company’s inventory increased by 9.17% to ¥326.33 million, indicating a buildup of stock in anticipation of future sales[15] - Accounts receivable increased to ¥568,520,994.14 as of March 31, 2021, compared to ¥470,397,763.18 at the end of 2020, reflecting improved sales performance[31] - Inventory levels rose to ¥326,330,364.85 as of March 31, 2021, up from ¥298,915,970.20 at the end of 2020, indicating increased production activity[31] Tax and Expenses - The company reported a 97.78% increase in income tax expenses to ¥17.54 million, driven by a substantial rise in profitability[15] - The company incurred tax expenses of CNY 9,750,231.06 in Q1 2021, compared to CNY 674,183.23 in the same period last year[41] Operational Insights - The company reported government subsidies of ¥436,777.60 during the period[9] - The company reported that the order production for Q4 2020 was fully booked, indicating strong demand[26] - The company anticipates that the Q1 2021 orders are expected to be robust, maintaining full production capacity[27] - The company is closely monitoring government policies related to carbon neutrality and plans to develop corresponding strategies[27] - The company faced challenges in 2019 due to rising operational costs and tariffs, which significantly impacted its performance that year[27]